Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women
- 24 February 2010
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 42 (6-7) , 522-526
Abstract
Although infections with multiple human papillomavirus (HPV) types have been reported widely, more information is needed on the occurrence of the different types. We determined the distribution of seroprevalences to multiple HPV types in Finland and Uganda to compare the epidemiology of the different HPV types in the 2 populations. Serum samples were obtained from 2784 Finnish and 1964 Ugandan women (mean ages 22 y and 25 y, respectively) of whom 44% and 57%, respectively, had antibodies to at least 1 of the 7 HPV types (6, 11, 16, 18, 31, 33, 45) tested (p < 0.001). Multiple HPV antibody positivity was common. HPV45-seropositive Finns had a higher risk of having antibodies to other high-risk HPV types: HPV18 (odds ratio (OR) = 10.9), HPV31 (OR 6.1), HPV33 (OR 12.2), than their Ugandan counterparts: HPV18 (OR 3.4), HPV31 (OR 2.2), HPV33 (OR 3.3). Increased estimates for being double antibody-positive were also noted among HPV18- and HPV16-seropositive women, but there were no major differences between HPV16-seropositive Finns and Ugandans. In addition to biological and behavioural factors, iatrogenic and societal factors (screening vs no screening) may also result in the different occurrence of infections with the high-risk HPV types in Finland and Uganda.Keywords
This publication has 17 references indexed in Scilit:
- Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d’Ivoire and Finland) with different tobacco exposureCancer Causes & Control, 2008
- Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, UgandaInternational Journal of Cancer, 2008
- Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infectionScandinavian Journal of Infectious Diseases, 2008
- Seroprevalence atlas of infections with oncogenic and non‐oncogenic human papillomaviruses in Finland in the 1980s and 1990sInternational Journal of Cancer, 2006
- Human Papillomavirus Infections with Multiple Types and Risk of Cervical NeoplasiaCancer Epidemiology, Biomarkers & Prevention, 2006
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study.Journal of General Virology, 1999
- Stability over Time of Serum Antibody Levels to Human Papillomavirus Type 16The Journal of Infectious Diseases, 1998
- Seropositivities to Human Papillomavirus Types 16, 18, or 33 Capsids and to Chlamydia trachomatis Are Markers of Sexual BehaviorThe Journal of Infectious Diseases, 1996